Trials that use: Interim analysis / alpha spending
New to this method? Read the tutorial →
4,594 results
- Dalantercept in Treating Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer: Complete Statistical AnalysisIndependent statistical analysis of Dalantercept in Treating Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Dalteparin for Primary Venous Thromboembolism (VTE) Prophylaxis in Pancreatic Cancer Patients: Complete Statistical AnalysisIndependent statistical analysis of Dalteparin for Primary Venous Thromboembolism (VTE) Prophylaxis in Pancreatic Cancer Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- DAPPERIndependent statistical analysis of Depression and Pain Perseverance Through Empowered Recovery Intervention: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04091347).
- DAR-PIAIndependent statistical analysis of DAR-901 TB Booster Vaccine to Prevent TB in Adolescents: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02712424).
- Daratumumab in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome: Complete Statistical AnalysisIndependent statistical analysis of Daratumumab in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Daratumumab Retreatment in Participants With Multiple Myeloma Who Have Been Previously Treated With Daratumumab: Complete Statistical AnalysisIndependent statistical analysis of Daratumumab Retreatment in Participants With Multiple Myeloma Who Have Been Previously Treated With Daratumumab: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Dasatinib and Bevacizumab in Treating Patients With Recurrent or Progressive High-Grade Glioma or Glioblastoma Multiforme: Complete Statistical AnalysisIndependent statistical analysis of Dasatinib and Bevacizumab in Treating Patients With Recurrent or Progressive High-Grade Glioma or Glioblastoma Multiforme: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Dasatinib in Treating Patients With Previously Treated Metastatic Colorectal Cancer: Complete Statistical AnalysisIndependent statistical analysis of Dasatinib in Treating Patients With Previously Treated Metastatic Colorectal Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00504153).
- Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma: Complete Statistical AnalysisIndependent statistical analysis of Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00423735).
- Dasatinib in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer: Complete Statistical AnalysisIndependent statistical analysis of Dasatinib in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Data Analysis for Drug Repurposing for Effective Alzheimer’s Medicines (DREAM)- Propranolol/Carvedilol Versus Atenolol/Bisoprolol/Sotalol: Complete Statistical AnalysisIndependent statistical analysis of Data Analysis for Drug Repurposing for Effective Alzheimer's Medicines (DREAM)- Propranolol/Carvedilol Versus Atenolol/Bisoprolol/Sotalol: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- DATASIndependent statistical analysis of DATAS: The Dual Chamber & Atrial Tachyarrhythmias Adverse Events Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00157820).
- DaxibotulinumtoxinA for Injection for the Treatment of Plantar Fasciitis: Complete Statistical AnalysisIndependent statistical analysis of DaxibotulinumtoxinA for Injection for the Treatment of Plantar Fasciitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03825315).
- DAYBREAK-ALZIndependent statistical analysis of A Study of Lanabecestat (LY3314814) in Participants With Mild Alzheimer's Disease Dementia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Daytime vs. Delayed Eating Among Obese Individuals: Complete Statistical AnalysisIndependent statistical analysis of Daytime vs. Delayed Eating Among Obese Individuals: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03354169).
- DEARIndependent statistical analysis of Dose Escalation and Remission (DEAR): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00652145).
- DEBRAIndependent statistical analysis of Investigating the Causal Role of Prefrontal Control in Decision-making in Patients With Anhedonia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- DECIFERIndependent statistical analysis of DECIFER: Depression and Citalopram In First Episode Recovery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01041274).
- Decision Aid for Therapeutic Options In Sickle Cell Disease: Complete Statistical AnalysisIndependent statistical analysis of Decision Aid for Therapeutic Options In Sickle Cell Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02326597).
- Decision Support for Smoking Cessation in Young Adults With Severe Mental Illness: Complete Statistical AnalysisIndependent statistical analysis of Decision Support for Smoking Cessation in Young Adults With Severe Mental Illness: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Decision-aid on Breast Cancer Screening: Complete Statistical AnalysisIndependent statistical analysis of Decision-aid on Breast Cancer Screening: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03097653).
- Decitabine and Clofarabine in Higher Risk Myelodysplastic Syndromes (MDS): Complete Statistical AnalysisIndependent statistical analysis of Decitabine and Clofarabine in Higher Risk Myelodysplastic Syndromes (MDS): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00903760).
- Decitabine and Gemtuzumab Ozogamicin in Acute Myelogenous Leukemia and High-risk Myelodysplastic Syndrome: Complete Statistical AnalysisIndependent statistical analysis of Decitabine and Gemtuzumab Ozogamicin in Acute Myelogenous Leukemia and High-risk Myelodysplastic Syndrome: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Decitabine and Tretinoin in Treating Patients With Myelodysplastic Syndromes: Complete Statistical AnalysisIndependent statistical analysis of Decitabine and Tretinoin in Treating Patients With Myelodysplastic Syndromes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00382200).
- Decitabine Followed by Idarubicin and Cytarabine in Treating Patients With Relapsed or Refractory AML and MDS: Complete Statistical AnalysisIndependent statistical analysis of Decitabine Followed by Idarubicin and Cytarabine in Treating Patients With Relapsed or Refractory AML and MDS: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Deep Brain Stimulation for Major Depressive Disorder: Complete Statistical AnalysisIndependent statistical analysis of Deep Brain Stimulation for Major Depressive Disorder: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00617162).
- DEFEAT-PEIndependent statistical analysis of Detect Fluid Early From Intra-thoracic Impedance Monitoring: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00916929).
- DEFUSE 3Independent statistical analysis of Endovascular Therapy Following Imaging Evaluation for Ischemic Stroke 3: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02586415).
- Dehydroepiandrosterone (DHEA) Against Vaginal Atrophy: Complete Statistical AnalysisIndependent statistical analysis of Dehydroepiandrosterone (DHEA) Against Vaginal Atrophy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01358760).
- Delirium Treatment With Acupuncture in Internal Medicine Departments: Complete Statistical AnalysisIndependent statistical analysis of Delirium Treatment With Acupuncture in Internal Medicine Departments: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03398928).
- DelishIndependent statistical analysis of Delish Study: Diabetes Education to Lower Insulin, Sugars, and Hunger: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03207711).
- DELISH R33Independent statistical analysis of (R33 Phase) DELISH Study: Diabetes Education to Lower Insulin, Sugars, and Hunger: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Dendritic Cell Therapy, Cryosurgery, and Pembrolizumab in Treating Patients With Non-Hodgkin Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of Dendritic Cell Therapy, Cryosurgery, and Pembrolizumab in Treating Patients With Non-Hodgkin Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- DEPICT 1Independent statistical analysis of Dapagliflozin Evaluation in Patients With Inadequately Controlled Type 1 Diabetes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02268214).
- Depression-Diabetes Mechanisms: Urban African Americans: Complete Statistical AnalysisIndependent statistical analysis of Depression-Diabetes Mechanisms: Urban African Americans: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00209170).
- Depsipeptide in Unresectable Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck: Complete Statistical AnalysisIndependent statistical analysis of Depsipeptide in Unresectable Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Dermal Safety Study to Evaluate Potential Irritation of Abametapir Lotion: Complete Statistical AnalysisIndependent statistical analysis of Dermal Safety Study to Evaluate Potential Irritation of Abametapir Lotion: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02061813).
- Dermatome Electrical Stimulation on Individuals With Overweight and Class I Obesity: Complete Statistical AnalysisIndependent statistical analysis of Dermatome Electrical Stimulation on Individuals With Overweight and Class I Obesity: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Desaturation Validation of INVSENSOR00006: Complete Statistical AnalysisIndependent statistical analysis of Desaturation Validation of INVSENSOR00006: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03435211).
- Desensitization in Kidney Transplantation: Complete Statistical AnalysisIndependent statistical analysis of Desensitization in Kidney Transplantation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00908583).
- Design and Implementation of a Nutritional Intervention in Patients With Oropharyngeal Dysphagia: Complete Statistical AnalysisIndependent statistical analysis of Design and Implementation of a Nutritional Intervention in Patients With Oropharyngeal Dysphagia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Design and Testing of a Web-Based Tool for the Improvement of End-of-Life Planning in Patients With Advanced Cancer: Complete Statistical AnalysisIndependent statistical analysis of Design and Testing of a Web-Based Tool for the Improvement of End-of-Life Planning in Patients With Advanced Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Desmopressin Acetate 0.2 mg Tablets, Fasting: Complete Statistical AnalysisIndependent statistical analysis of Desmopressin Acetate 0.2 mg Tablets, Fasting: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00835211).
- DESTINATIONIndependent statistical analysis of Extension Study to Evaluate the Safety and Tolerability of Tezepelumab in Adults and Adolescents With Severe, Uncontrolled Asthma: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Detection of Barrett s Esophagus in Patients Without GERD Symptoms: Complete Statistical AnalysisIndependent statistical analysis of Detection of Barrett s Esophagus in Patients Without GERD Symptoms: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04880044).
- Determine the Efficacy and Safety of Harvoni in Genotype 1 Chronic Hepatitis c Infected People Who Are Alcoholics: Complete Statistical AnalysisIndependent statistical analysis of Determine the Efficacy and Safety of Harvoni in Genotype 1 Chronic Hepatitis c Infected People Who Are Alcoholics: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- DeuceIndependent statistical analysis of Functional Performance of the Journey Deuce Bicompartmental Versus the Genesis II Total Knee System: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Developing an Activity Pacing Framework: Feasibility and Acceptability: Complete Statistical AnalysisIndependent statistical analysis of Developing an Activity Pacing Framework: Feasibility and Acceptability: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03497585).
- Developing and Validating Fertilit-e: Complete Statistical AnalysisIndependent statistical analysis of Developing and Validating Fertilit-e: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03599661).
- Development of Childhood Anti-Influenza Immunity: Complete Statistical AnalysisIndependent statistical analysis of Development of Childhood Anti-Influenza Immunity: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03673345).